Meaningful use stage 3 is not scheduled to start until 2017, but 41 medical societies are calling to delay the start of stage 3, especially given recent changes to Medicare.
Meaningful use stage 3 is not scheduled to start until 2017, but 41 medical societies, including the American Medical Association (AMA), American College of Physicians, and the American Society of Hematology, are calling to delay the start of stage 3, especially given recent changes to Medicare.
These medical societies are backing Senator Lamar Alexander, who believes the meaningful use program should be paused given the need to improve usability and interoperability of electronic health records.
"Proper reassessment of the program before implementing the final stage of regulations will help avoid problematic software that physicians and patients will be burdened with for years to come," AMA President Steven J. Stack, MD, said in response to Alexander's calls for delay.
Now the coalition of physician organizations has delivered letters to HHS Secretary Sylvia Mathews Burwell and Office of Management and Budget Director Shaun Donovan explaiing that locking in rules for stage 3 of the meaningful use program would undermine the implementation of Medicare payment reforms. They point out that proposed meaningful use stage 3 rules were "developed prior to and without consideration of the changes enacted by the Medicare Access and CHIP Reauthorization Act (MACRA)."
The program will play an important role in payment reforms introduced by the legislation, the societies argue, and therefore proposed stage 3 rules could impede healthcare delivery innovations Congress seeks through the passage of MACRA.
“The AMA wants the Meaningful Use program to succeed,” said Dr Stack. "Pausing to reassess Stage 3 rules will not stop or delay progress with EHRs. On the contrary, we firmly believe a temporary period of reevaluation will help move the program forward and drive innovation and adoption.”
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More